Covered recipient · General Payments record
ANJALI T SIBLEY
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$952.37
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $234.02 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $45.27 | 2 |
| GlaxoSmithKline, LLC. | $32.25 | 1 |
| Celgene Corporation | $31.09 | 1 |
| Merck Sharp & Dohme Corporation | $26.63 | 1 |
| EISAI INC. | $26.62 | 1 |
| ARRAY BIOPHARMA INC | $26.41 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $25.15 | 1 |
| SpringWorks Therapeutics, Inc. | $20.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.90 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106096507 | CMS |
| ABBVIE INC. | $20.37 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106096509 | CMS |
| ARRAY BIOPHARMA INC | $26.41 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131474263 | CMS |
| Celgene Corporation | $31.09 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101114058 | CMS |
| Eisai Inc. | $26.62 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110730223 | CMS |
| GlaxoSmithKline, LLC. | $32.25 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116432357 | CMS |
| Merck Sharp & Dohme LLC | $26.63 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141677513 | CMS |
| Novartis Pharmaceuticals Corporation | $25.15 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087340697 | CMS |
| SpringWorks Therapeutics, Inc. | $20.60 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1085808131 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.